Bosh sahifaSTTPF • OTCMKTS
add
SCHOTT Pharma AG & Co KgaA
Bozor kapitalizatsiyasi
2,27 mlrd EUR
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
ETR
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (EUR) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 247,58 mln | 4,44% |
Joriy xarajat | 35,95 mln | 84,91% |
Sof foyda | 33,56 mln | -1,23% |
Sof foyda marjasi | 13,55 | -5,44% |
Har bir ulushga tushum | 0,22 | 0,00% |
EBITDA | 56,70 mln | -14,67% |
Amaldagi soliq stavkasi | 19,37% | — |
Balans
Jami aktivlari
Jami passivlari
| (EUR) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 25,67 mln | -2,89% |
Jami aktivlari | 1,60 mlrd | 11,18% |
Jami passivlari | 704,90 mln | 8,54% |
Umumiy kapital | 893,75 mln | — |
Tarqatilgan aksiyalar | 150,61 mln | — |
Narxi/balansdagi bahosi | — | — |
Aktivlardan daromad | 6,42% | — |
Kapitaldan daromad | 8,54% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (EUR) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 33,56 mln | -1,23% |
Operatsiyalardan naqd pul | 52,34 mln | -30,60% |
Sarmoyadan naqd pul | -70,87 mln | 59,28% |
Moliyadan naqd pul | 12,59 mln | -87,50% |
Naqd pulning sof oʻzgarishi | -5,82 mln | -665,40% |
Boʻsh pul | -21,57 mln | -215,74% |
Haqida
Schott Pharma is a provider of drug containment solutions and delivery systems for injectable drugs. Originally a division of glass manufacturer Schott AG, the company went public on the Frankfurt Stock Exchange in 2023. Headquartered in Mainz, Germany, the company operates in 14 countries. Wikipedia
Tashkil etilgan
1-avg, 2022
Xodimlar soni
4 716
